PathoNostics is a molecular diagnostics company offering real-time PCR assays for yeast- and fungal infections. Our technology combines amplification for detection and melting curve analysis for identification of the pathogen and/or resistance marker.

We currently have two CE-IVD certified products on the market: AsperGenius® for the detection of Aspergillus species and tri-azole resistance, and DermaGenius® for the detection and differentiation of Candida albicans & dermatophyte species. 

PathoNostics

Multicentre validation of the AsperGenius® assay published in JAC

Thursday, August 18, 2016 – The manuscript ‘PCR-based detection of Aspergillus fumigatus Cyp51A mutations on bronchoalveolar lavage: a multicentre validation of the AsperGenius® assay in 201 patients with haematological disease suspected for invasive aspergillosis’ is now published online on PubMed.